Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carisbamate in partial onset seizures
NCT00433667Phase 3Completed
- Sponsor
- SK Life Science, Inc.
- Start
- Nov 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of carisbamate in focal onset seizure (3 arms), sponsored by SK Life Science, Inc. Primary endpoint: Percent reduction from baseline in monthly partial onset seizure frequency at 12 weeks. Started Nov 2006; status: completed.
02
Drugs
carisbamate
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT00433667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00433667.